Navigation Links
Nyer Medical Group, Inc. Announces Sale of Company's Florida Medical-Surgical Division; Pharmacy Division Awarded Two-Year Preferred Supplier Contract
Date:7/9/2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2008)...theast region with more hires,planned throughout t...ug. 28 /PRNewswire-USNewswire/ -- The Pennsylvania...ty Liaison for the,Northeast region to help health...tient Safety Reporting System (PA-PSRS) improve pa...ar in focus groups with Pennsylvania Patient Safet...
(Date:8/28/2008)...ology company serves growing professional and cons...Palo Alto, CA (PRWEB) August 28, 2008 -- Trident C...ay announced that together with Mustang Ventures, ...es A round of financing for Profex.Inc. Trident Ca...5 million in the round. Profex, a leading Dermatol...
(Date:8/28/2008)...tself, associated with increased plaque , ...of researchers has described hourly changes in a p...role in Alzheimer,s disease. , In a 2005 study... linked to brain cell communication in a mouse mod...cation increased, so did amyloid beta. When there ...
(Date:8/28/2008)...ion Council for Continuing Medical Education (ACCM...ge of American Pathologists (CAP) the status of Ac...tinuing medical education for physicians. , ...8, 2008 -- The Accreditation Council for Continuin...ion Division of the www.cap.org [College of Amer...
Breaking Medicine News(10 mins):Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3Health News:Trident Capital and Mustang Ventures Lead Series A Investment in Profex, Inc. 2Health News:Trident Capital and Mustang Ventures Lead Series A Investment in Profex, Inc. 3Health News:Scientists Track Hourly Changes in Alzheimer's Protein 2Health News:College of American Pathologists' Education Division Receives Top Honor 2Health News:College of American Pathologists' Education Division Receives Top Honor 3
...next to breast cancer in women and is the main cau... of cervical cancer would help in early treatment ...ervical cancer. A cytologic screening test known a...s of cervical cancer in its preinvasive state and ...
...released tips to help prevent the building up of s...National Heart Month.// Research has shown that 20...n adverse impact on their health and 20 percent de...eving a healthy lifestyle comes from adopting beha...
...e committed suicide five months ago using a lethal...as suffering from degenerative disease// which mad.... Mrs. Murphy wanted to end her life to escape fr...gnitas Clinic in Zurich. Mrs. Murphy went to Zuric...
...rom the sky in the Indian State of West Bengal on ...ace at the Katnabil Village, resulting in a flutte... as absurd by weather experts. The ice is reported...the time a photographer arrived at the site. <...
Other Medicine News:
(Date:8/27/2008)...atients in the VELCADE, melphalan and prednisone a...s well as a 30 percent complete response -, CAMBR...he Takeda,Oncology Company today announced the pub...ed, Phase III VISTA(1) trial in this week,s editio...lts showed a significant survival,benefit and a 30...
(Date:8/27/2008)...TONY, France, August 27 /-,...cal Results in a,Pharmacodynamic Study Conducted i.... announces the highly positive results of a new s...CC)., The study on Oralair(R) Grasses included 86...with different treatment durations: 1 week, 1 mont...
(Date:8/27/2008)... First Phase 3 data, from BLISS-52 trial, expected...BLISS-76, expected by fall 2009 -, ROCKVILLE, Md....ciences, Inc. (Nasdaq: HGSI ) today announced it ...SS-76, the second of two pivotal Phase 3,randomize...n patients with,active systemic lupus erythematosu...
(Date:8/26/2008)... Company to present data from landmark SYNTAX cli...irstCall/ -- Boston Scientific,Corporation (NYSE: ...,s major,events and press announcements at the Eur...uns from August 30 to September 3 in Munich, Germa...from the SYNTAX trial,which compares percutaneous...
Breaking Medicine Technology:New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 2New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 4New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 5New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 6Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 2Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 2Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 3Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 4NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia Bipolar Disorder and Depression 2233 1NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia Bipolar Disorder and Depression 2233 2NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia Bipolar Disorder and Depression 2233 3NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia Bipolar Disorder and Depression 2233 4NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia Bipolar Disorder and Depression 2233 5NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia Bipolar Disorder and Depression 2233 6AMT Announces Positive Interim Clinical Data on its Lead Product AMT 011 2230 1AMT Announces Positive Interim Clinical Data on its Lead Product AMT 011 2230 2AMT Announces Positive Interim Clinical Data on its Lead Product AMT 011 2230 3The Childrens Hospital of Philadelphia Ranks Number One in U S News 26 World Reports 2008 Edition of Americas Best Childrens Hospitals 20639 1The Childrens Hospital of Philadelphia Ranks Number One in U S News 26 World Reports 2008 Edition of Americas Best Childrens Hospitals 20639 2The Childrens Hospital of Philadelphia Ranks Number One in U S News 26 World Reports 2008 Edition of Americas Best Childrens Hospitals 20639 3The Childrens Hospital of Philadelphia Ranks Number One in U S News 26 World Reports 2008 Edition of Americas Best Childrens Hospitals 20639 4A common aquatic animals genome can capture foreign DNA 3478 1A common aquatic animals genome can capture foreign DNA 3478 2
...007 /PRNewswire-FirstCall/ --,CuraGen Corporation ...y interim clinical data on intravenous belinostat,...eing investigated,for the treatment of cancer, are...dical meetings. , One oral and one poster presenta...nostat will be made at the 2007 American Society,o...
...2007 /PRNewswire-FirstCall/ --,Idenix Pharmaceutic... the discovery, development and commercialization ...r infectious diseases,announced today that 11 abs...2007 Digestive Disease Week (DDW) meeting, to,be h...ract contents,are available on the DDW web site at...
Other Medicine Technology:CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 2CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 3CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 4CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 5Idenix Announces Data Presentations at the 2007 Digestive Disease,Week Meeting 2Idenix Announces Data Presentations at the 2007 Digestive Disease,Week Meeting 3Idenix Announces Data Presentations at the 2007 Digestive Disease,Week Meeting 4Idenix Announces Data Presentations at the 2007 Digestive Disease,Week Meeting 5Idenix Announces Data Presentations at the 2007 Digestive Disease,Week Meeting 6Idenix Announces Data Presentations at the 2007 Digestive Disease,Week Meeting 7
...cs Histoplasma DxSelect is intended for qualitativ... var. capsulatum in human serum. The test is indic...atory disease, as an aid in the presumptive labora... is not intended for self-testing, and this test i...
Indirect immunofluorescent antibody (IFA) test for the detection and semi-quantitation of human serum IgG antibodies to Epstein-Barr viral capsid antigen (VCA). Each kit contains ten 12-well slides,
...s a portable, battery-powered, micro-controlled, n...adjunct electromagnetic treatment to primary lumba...is treatment has been shown in pre-clinical studie...ing. Clinical studies have also shown that individ...
...utions introduces its new multifunctional lithotri...e patient data management is the perfect symbiosis... is an engineering masterpiece for lithotripsy and...lithotripsy, endourology, urodiagnostics, percutan...
Medicine Products: